The production of chromosomal alterations in human lymphocytes by drugs known to interfere with the activity of DNA topoisomerase II. I. m-AMSA
- 1 January 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 10 (1) , 123-130
- https://doi.org/10.1093/carcin/10.1.123
Abstract
The frequencies of chromosomal aberrations and sister chromatid exchanges (SCE) were studied in human peripheral lymphocytes after exposure of whole blood cultures to the antitumour agent m-AMSA. Chromosome-type aberrations were found in cells exposed before stimulation or during the G1-phase of the cell cycle. Chromatid-type aberrations were obtained in cells exposed during the S- and G2-phases, but also in cells exposed in the G1-phase or before stimulation. Treatment of lymphocytes with m-AMSA in the G1-phase or before stimulation had the additional effect of strongly increasing the frequency of SCE. When unstimulated lymphocytes were exposed to m-AMSA, the frequencies of SCE and chromatid-type aberrations, but not the frequency of chromosome-type aberrations, could be strongly reduced by holding the cells in F-10 for 2–4 h before stimulation, or by changing the growth medium after stimulation. A 1-h incubation in growth medium was sufficient for obtaining this reduction. The medium in which the m-AMSA-treated cells were incubated for the first 3 h after stimulation proved to be capable of inducing chromatid-type aberrations in late S/G2-phase and SCEs in the S-phase. These observations show that the chromatid-type aberrations and SCEs obtained by exposing unstimulated lymphocytes to m-AMSA were not produced during the treatment itself, but after stimulation at an advanced stage of the cell cycle by an active substance (m-AMSA or a metabolite of m-AMSA) released into the medium during the first hours of incubation. Post-treatments in G2 with 1-β-D-arabinofuranosylcytosine (ara-C) and hydroxyurea strongly enhanced the frequency of chromatidtype aberrations obtained after treatment of stimulated or unstimulated lymphocytes with m-AMSA. Post-treatments in unstimulated or G1-phase lymphocytes with ara-C did not influence the frequency of chromosome-type aberrations induced by m-AMSA at these stages, but strongly enhanced those induced by X-rays.Keywords
This publication has 25 references indexed in Scilit:
- CYTOGENETIC EFFECTS OF AMSACRINE ON HUMAN-LYMPHOCYTES INVIVO AND INVITRO1984
- RELATIONSHIP BETWEEN THE INDUCTION OF CHROMOSOME-DAMAGE AND CYTO-TOXICITY FOR AMSACRINE AND CONGENERS1984
- Enzymatic Restriction of Mammalian Cell DNA Using Pvu II and Bam H1: Evidence for the Double-strand Break Origin of Chromosomal AberrationsInternational Journal of Radiation Biology, 1984
- Cooperative sequestration of m-AMSA in L1210 cellsBiochemical Pharmacology, 1982
- Formation and resealing of intercalator-induced DNA strand breaks in permeabilized L1210 cells without the stimulated synthesis of poly(ADP-ribose).Journal of Biological Chemistry, 1982
- The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nucleiBiochemical and Biophysical Research Communications, 1982
- Mechanisms for chromosomal aberrations in mammalian cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1982
- DNA-repair deficiencies do not affect intercalator-induced cytotoxicity or DNA scission in human cellsMutation Research Letters, 1982
- Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino)methanesulfon-m-anisidide and adriamycinBiochemistry, 1981
- Cell-Cycle-Specific Chromosome Damage Following Treatment of Cultured Chinese Hamster Cells With 4′-[(9-Acridinyl-amino] methanesulphon-m-anisidide-HCl2JNCI Journal of the National Cancer Institute, 1978